Identification of patients at risk from ischaemic complications
1Cardiac Department, Wythenshawe Hospital, Manchester, UK.
Insights
Beta-blockers effectively reduce cardiovascular risks, particularly myocardial infarction, by addressing factors like blood pressure and circadian rhythms. They offer significant benefits in both primary and secondary prevention for specific patient groups.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Cardiovascular disease involves multiple risk factors including blood pressure, left ventricular hypertrophy, stress, and smoking.
- Certain cardiovascular events and risk factors exhibit a distinct circadian rhythm, with a notable peak in the mid-morning hours.
Purpose of the Study:
- To evaluate the efficacy of beta-blockers in managing cardiovascular disease risk factors and events.
- To compare the effectiveness of beta-blockers with other medications like ACE inhibitors and calcium antagonists.
- To assess the role of beta-blockers in primary and secondary prevention of cardiovascular events.
Main Methods:
- Comparative analysis of beta-blockers against ACE inhibitors and calcium antagonists.
- Evaluation of beta-blocker effects on left ventricular mass, wall thickness, and myocardial necrosis.
- Assessment of beta-blocker impact on circadian variations in cardiovascular events, particularly mid-morning ischaemic events and myocardial infarction.
Main Results:
- Beta-blockers show modest reversal of left ventricular mass compared to ACE inhibitors but similar effects on posterior wall and septal thickness.
- Beta-blockers effectively reduce mid-morning ischaemic events and myocardial infarction risk, correlating with peak catecholamine levels.
- Beta-blockers are more effective than calcium antagonists in mitigating the mid-morning vulnerable period and reducing ischaemia duration.
- In younger hypertensives, beta-blockers outperform diuretics for primary prevention; they are superior to calcium antagonists in secondary prevention post-myocardial infarction.
Conclusions:
- Beta-blockers are highly beneficial for patients with hypertension and ischaemic heart disease.
- Beta-blockers play a crucial role in managing circadian risk patterns and preventing acute cardiovascular events.
- The study highlights the importance of considering drug class efficacy for specific patient populations and prevention strategies, while acknowledging limitations of surrogate endpoints.
Abstract:
Several risk factors for cardiovascular disease are discussed, including blood pressure, left ventricular hypertrophy, stress and smoking. Beta-blockers have a modest effect in reversing increased left ventricular mass, compared with angiotensin converting enzyme (ACE) inhibitors, although beta-blockers are as effective as ACE inhibitors in reducing posterior wall and interventricular septal thickness. Coronary events and many risk factors show a circadian rhythm. Beta-blockers can reduce the mid-morning (0700-1000 h) risk of ischaemic events and myocardial infarction. Catecholamine levels peak at 0700-1000 h, and catecholamine-induced myocardial necrosis can be significantly reduced by beta-blockade. Beta-blockers appear to be more effective than calcium antagonists in modifying the mid-morning vulnerable period and reducing the duration of ischaemia. However, the problems of using surrogate endpoints are discussed. In young to middle-aged hypertensives, beta-blockers are more effective in primary prevention of myocardial events than diuretics, though this is not the case for the elderly. Beta-blockers are also more effective than calcium antagonists in reducing morbidity and mortality after a myocardial infarction (i.e. secondary prevention). Patients with hypertension associated with ischaemic heart disease are most likely to get maximal benefit from treatment with beta-blockers.
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
09:36A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
Published on: August 12, 2025
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:20Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:26Exercise Stress Test
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests